IO Biotech (IOBT) Institutional Ownership $0.77 +0.01 (+1.42%) (As of 12:09 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for IO Biotech (NASDAQ:IOBT)CurrentInstitutional OwnershipPercentage54.76%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.89MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$3.11M Get IOBT Insider Trade Alerts Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IOBT Institutional Buying and Selling by Quarter Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. IO Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/24/2024 Novo Holdings A S3,354,449$3.52M0.2%-24.3%5.092% 8/20/2024 Novo Holdings A S4,429,449$5.18M0.3%-12.9%6.723% 8/15/2024 Armistice Capital LLC1,545,000$1.81M0.0%-10.4%2.345% 8/12/2024 XTX Topco Ltd26,555$31K0.0%+67.4%0.040% 8/9/2024 Renaissance Technologies LLC180,800$212K0.0%+8.1%0.274% 2/15/2024 PFM Health Sciences LP2,341,107$4.40M0.3%+73.0%3.554% 2/13/2024 Stonepine Capital Management LLC1,666,037$3.13M1.4%-15.7%2.529% 2/13/2024 Armistice Capital LLC1,924,000$3.62M0.0%-10.4%2.920% 11/15/2023 Armistice Capital LLC2,148,000$3.03M0.0%N/A3.260% 11/14/2023 Stonepine Capital Management LLC1,975,308$2.79M0.9%N/A2.998% 11/14/2023 Pivotal bioVenture Partners Investment Advisor LLC864,197$1.22M0.5%N/A1.312% 11/8/2023 Vivo Capital LLC6,173,439$8.71M1.1%+104.7%9.371% 7/25/2023 Summit Trail Advisors LLC43,744$86K0.0%N/A0.152% 2/14/2023 RA Capital Management L.P.1,127,260$2.59M0.1%-39.3%3.911% 11/14/2022 Psagot Value Holdings Ltd. Israel40,846$111K0.0%N/A0.142% 11/2/2022 Victory Capital Management Inc.43,741$119K0.0%N/A0.152% 2/15/2022 Samsara BioCapital LLC1,120,437$7.17M1.4%N/A3.888% 2/15/2022 Capital World Investors1,235,000$8.11M0.0%N/A4.286% 2/14/2022 Soleus Capital Management L.P.672,734$4.31M0.4%N/A2.335% 2/14/2022 Novo Holdings A S3,277,932$20.98M1.0%N/A11.376% (Data available from 1/1/2016 forward) IOBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IOBT shares? During the previous two years, 10 institutional investors and hedge funds held shares of IO Biotech. The most heavily invested institutionals were Vivo Capital LLC ($8.71M), PFM Health Sciences LP ($4.40M), Novo Holdings A S ($3.52M), Stonepine Capital Management LLC ($3.13M), RA Capital Management L.P. ($2.59M), Armistice Capital LLC ($1.81M), and Pivotal bioVenture Partners Investment Advisor LLC ($1.22M).Learn more on IOBT's institutional investors. What percentage of IO Biotech stock is owned by institutional investors? 54.76% of IO Biotech stock is owned by institutional investors. Learn more on IOBT's institutional investor holdings. Which institutional investors have been buying IO Biotech stock? The following institutional investors have purchased IO Biotech stock in the last 24 months: Vivo Capital LLC ($3.16M), Armistice Capital LLC ($2.15M), Stonepine Capital Management LLC ($1.98M), PFM Health Sciences LP ($987.65K), Pivotal bioVenture Partners Investment Advisor LLC ($864.20K), Summit Trail Advisors LLC ($43.74K), and Renaissance Technologies LLC ($13.60K). How much institutional buying is happening at IO Biotech? Institutional investors have bought a total of 9,201,085 shares in the last 24 months. This purchase volume represents approximately $13.46M in transactions. Which IO Biotech major shareholders have been selling company stock? The following institutional investors have sold IO Biotech stock in the last 24 months: Novo Holdings A S ($1.73M), RA Capital Management L.P. ($730.50K), Armistice Capital LLC ($403K), and Stonepine Capital Management LLC ($309.27K). How much institutional selling is happening at IO Biotech? Institutional investors have sold a total of 3,176,575 shares in the last 24 months. This volume of shares sold represents approximately $4.79M in transactions. Related Companies MacroGenics Institutional Ownership Inhibrx Institutional Ownership Biomea Fusion Institutional Ownership SOPHiA GENETICS Institutional Ownership Fulcrum Therapeutics Institutional Ownership Opthea Institutional Ownership Ventyx Biosciences Institutional Ownership Kyverna Therapeutics Institutional Ownership Cybin Institutional Ownership Amarin Institutional Ownership This page (NASDAQ:IOBT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IO Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IOBT Stock Alerts